Methicillin-resistant Staphylococcus aureus and inducible resistance to clindamycin in patients from a Public Hospital in Ecuador
DOI:
https://doi.org/10.33936/qkrcs.v7i3.6256Abstract
Staphylococcus aureus is the cause of most nosocomial and community-acquired staphylococcus infections in humans. The current resistance of various microorganisms to antimicrobials constitutes a major health problem worldwide, where the excessive use of antibiotics has increased. selective pressure on bacteria, which has led to the emergence of drug resistance. In S. aureus. Resistance to methicillin (MRSA), which is a narrow-spectrum beta-lactam antibiotic from the penicillin group, is the most common mechanism acquired by this bacteria and increases the risk of acquiring soft tissue and skin infections. Another common and important resistance mechanism is towards macrolides (erythomycin), lincosamides (clindamycin) and streptogramins B or (MLSB) that have similar mechanisms and sites of action. With the purpose of evaluating the prevalence of methicillin-resistant Staphylococcus aureus and inducible resistance to clindamycin in patients treated at the Portoviejo General Hospital, this retrospective, cross-sectional, descriptive and observational investigation was carried out based on the collection of anonymized data. of which 57 (48.39%) bacteria showed resistance. A methicillin resistance profile of 21.18% was obtained, which was higher compared to the resistance to clindamycin with 11.1%, in addition, the considerable presence of both mechanisms was observed, present simultaneously and which is important from the point of view of clinically with 16.1%. The gender with the highest frequency of S. aureus isolates with resistance mechanisms was male with 80.7% and the average age was 46-60 years; Most of them came from injuries with 52.6% and from the Emergency area.
Keywords: Staphylococcus, resistance, antibiotic, methicillin, MLSB
Downloads
References
- Castellano-González M, Franquis-Rodríguez R, Perozo-Mena A, Sandoval-Castellano I. Susceptibilidad a meticilina y vancomicina en Staphylococcus aureus aislados de hemocultivos. Kasmera. 2020; 48(1). doi: 10.5281/zenodo.3712378
- Lee A, Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nature Reviews. 2018; 4(18033). DOI: http://dx.doi.org/10.1038/nrdp.2018.33
- Cabrera R, Fernández L, Motos A, López R, et al. Molecular characterization of methicillin- resistant Staphylococcus aureus clinical strains from the endotracheal tubes of patients with nosocomial pneumonia. Antimicro Resistan Infect Control. 2020; 9(43). https://doi.org/10.1186/s13756-020-0679-z
- Zurita J, Barba P, Ortega D, Mora M, Rivadeneira S. Local circulating clones of Staphylococcus aureus in Ecuador. Braz J Infect Dis. 2016; 20(6):525–533. DOI: ita). http://dx.doi.org/10.1016/j.bjid.2016.08.006
- Siqueira C, Gomes T, Pimenta J, Almeida e Borges L. Relato epidemiológico da resistência de Staphylococcus aureus resistente a meticilina em unidades de atendimento intensivo. Pubsaúde. 2022; 10: 348. DOI: https://dx.doi.org/10.31533/pubsaude10.a348
- Silvagni M, Guillén R, Rodríguez F, Espínola C. Resistencia inducible a clindamicina en Staphylococcus aureus resistentes a meticilina aislados de pacientes pediátricos en Paraguay. Rev Chilena Infectol. 2019; 36(4): 455-460.
- Tusa-Torres A, Gualpa-Jácome G, Echeverría-Llumipanta I. Indicadores de resistencia antimicrobiana en la unidad de cuidados intensivos en un hospital de Quito, Ecuador. Rev Cientif INSPILIP. 2021; 5(2): 1-7. DOI:10.31790/inspilip.v5i2.33
- Mantilla L, Buitrago E, Gurrero C, Navarro Y, Alvarado J. Infecciones por Staphylococcus aureus resistente a Meticilina en niños adquirida en la comunidad. Reporte de casos. Salud UIS. 2021: 53. doi: https://doi.org/10.18273/saluduis.53.e:21030
- Abdullahi I, Rabiu I, Bawa K, Abdulfatai K. Determination of Inducible Clindamycin Resistance Amongst Clinical Isolates of Methicillin-Resistant Staphylococcus aureus in Kaduna, Nigeria. JAMB, 2022; 22(1): 32-38. DOI: 10.9734/JAMB/2022/v22i130428
- Duquesne A, Castro N, et al. Caracterización microbiológica de aislamientos de Staphylococcus aureus en muestras purulentas. Hospital Ortopédico “Fructuoso Rodríguez”. Rev Panorama Cuba y Salud. 2015; 10(2): 17-22. Disponible en: https://revpanorama.sld.cu/index.php/panorama/article/view/476/pdf_5
- Ministerio de Salud Pública. Reporte de datos de resistencia a los antimicrobianos en Ecuador 2014-2018. [Internet]. 2019. Disponible en: https://www.salud.gob.ec/wp-content/uploads/2019/08/gaceta_ram2018.pdf
- Sujina M, Mehraj A, Pawan M, et al. Phenotypic detection of methicillin resistance, biofilm production, and inducible clindamycin resistance in Staphylococcus aureus clinical isolates in Kathmandu, Nepal. Tropical Medicine and Health. 2022; 50-71. DOI: https://doi.org/10.1186/s41182-022-00460-1
- Mohammed R, Mohammed M, Attia N, et al. Inducible clindamycin resistance in clinical isolates of staphylococcus aureus in Suez Canal University Hospital, Ismailia, Egypt. J Infect Dev Ctries. 2020; 14(11):1281-1287. DOI:10.3855/jidc.12250
- Instituto Nacional de Investigación en Salud Pública INSPI - Dr. Leonardo Izquieta Pérez. [Internet]. Perfiles de Susceptibilidad Antimicrobiana 2021. Disponible en: http://www.investigacionsalud.gob.ec/webs/ram/wp-content/uploads/2022/08/PERFILES-SUSCEPTIBILIDAD-2021.pdf
- Rossato A, Primon-Barros M, da Luz Rocha L. Resistance profile to antimicrobials agents in methicillin-resistant Staphylococcus aureus isolated from hospitals in South Brazil between 2014-2019. Rev Soc Bras Med Trop. 2020; 53. DOI: https://doi.org/10.1590/0037-8682-0431-2020
- Betrán A, Lapresta C, Lavilla M, et al. Bacteriemias por Staphylococcus aureus: factores de riesgo asociados a la resistencia a meticilina. Rev Cient Cienc Med. 2020; 23(1): 44-51. Disponible en: http://www.scielo.org.bo/pdf/rccm/v23n1/v23n1_a07.pdf
- Regmi R, Khadka S, Sapkota S, Adhikari S, et al. Phenotypic Detection of Inducible Clindamycin Resistance among Clinical Isolates of Staphylococcus aureus in Bharatpur Hospital. JCMS Nepal. 2019; 16(3):178-83. DOI: 10.3126/jcmsn.v16i3.28490
- Akhter S, Nazir A, Karnain O, Rouf M. Prevalence of Constitutive and Inducible Clindamycin Resistance among Methicillin-Resistant Staphylococcus aureus Isolates in a Tertiary Care Hospital, Kashmir Valley. J Med Microbiol Infect Dis. 2022; 10 (3): 104-113. DOI: 10.52547/JoMMID.10.3.104
- Gómez L, Núñez D, Perozo A, et al. Staphylococcus aureus con resistencia múltiple a los antibióticos (MDR) en un Hospital de Maracaibo Venezuela. Kasmera. 2016; 44(1): 53- 65. Disponible en: https://ve.scielo.org/pdf/km/v44n1/art08.pdf
- Morales G, Giovanetti M, Zuleta A, Núñez M. Detección fenotí- pica de susceptibilidad a meticilina, eritromicina y clindamicina en aislados de Staphylococcus spp. de un hospital de Valledupar (Colombia). Medicina & Laboratorio. 2017; 23: 65-74. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/61/44
Published
Issue
Section
License
Copyright (c) 2024 Sofía Caicedo Loor, Jorge Washington Pachay Solórzano

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.